Literature DB >> 26662852

NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice.

Annie-Carole Tosello-Trampont1, Peter Krueger1,2, Sowmya Narayanan1,2, Susan G Landes1, Norbert Leitinger3, Young S Hahn1,2.   

Abstract

UNLABELLED: Nonalcoholic steatohepatitis (NASH) affects 3%-5% of the U.S. population, having severe clinical complications to the development of fibrosis and end-stage liver diseases, such as cirrhosis and hepatocellular carcinoma. A critical cause of NASH is chronic systemic inflammation promoted by innate immune cells, such as liver macrophages (Mϕ) and natural killer (NK) cells. However, little is known about how the crosstalk between Mϕ and NK cells contributes to regulate NASH progression to fibrosis. In this report, we demonstrate that NKp46(+) cells play an important role in preventing NASH progression to fibrosis by regulating M1/M2 polarization of liver Mϕ. Using a murine model of NASH, we demonstrate that DX5(+)NKp46(+) NK cells are increased during disease and play a role in polarizing Mϕ toward M1-like phenotypes. This NK's immunoregulatory function depends on the production of interferon-gamma (IFN-γ), but not by granzyme-mediated cytolytic activity. Notably, depletion of NKp46(+) cells promotes the development of fibrosis with increased expression of profibrogenic genes as well as skewed M2 Mϕ phenotypes in hepatic tissues.
CONCLUSIONS: NK cell-derived IFN-γ may be essential for maintaining a balanced inflammatory environment that promotes tissue integrity and limiting NASH progression to fibrosis.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26662852      PMCID: PMC4764418          DOI: 10.1002/hep.28389

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.

Authors:  Virginia Maina; Salvatore Sutti; Irene Locatelli; Matteo Vidali; Cristina Mombello; Cristina Bozzola; Emanuele Albano
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

2.  IL-33--a cytokine which balances on a knife's edge?

Authors:  Annette Erhardt; Gisa Tiegs
Journal:  J Hepatol       Date:  2011-05-30       Impact factor: 25.083

3.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

4.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

Review 5.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

6.  In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

Authors:  Ogyi Park; Hua Wang; Honglei Weng; Lionel Feigenbaum; Hai Li; Shi Yin; Sung Hwan Ki; Seong Ho Yoo; Steven Dooley; Fu-Sheng Wang; Howard A Young; Bin Gao
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

7.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 8.  Organ-specific features of natural killer cells.

Authors:  Fu-Dong Shi; Hans-Gustaf Ljunggren; Antonio La Cava; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

9.  Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection.

Authors:  Michael J Davis; Tiffany M Tsang; Yafeng Qiu; Jeremy K Dayrit; Joudeh B Freij; Gary B Huffnagle; Michal A Olszewski
Journal:  MBio       Date:  2013-06-18       Impact factor: 7.867

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  47 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

Review 2.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

3.  Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.

Authors:  Wei Jiang; Daojing Li; Ranran Han; Chao Zhang; Wei-Na Jin; Kristofer Wood; Qiang Liu; Fu-Dong Shi; Junwei Hao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

Review 4.  Hypoxia-inducible factors and innate immunity in liver cancer.

Authors:  Vincent Wai-Hin Yuen; Carmen Chak-Lui Wong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

5.  XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Authors:  Assaf Weiner; Ziv Ben-Ari; Mathias Heikenwälder; Eran Elinav; Ido Amit; Aleksandra Deczkowska; Eyal David; Pierluigi Ramadori; Dominik Pfister; Michal Safran; Baoguo Li; Amir Giladi; Diego Adhemar Jaitin; Oren Barboy; Merav Cohen; Ido Yofe; Chamutal Gur; Shir Shlomi-Loubaton; Sandrine Henri; Yousuf Suhail; Mengjie Qiu; Shing Kam; Hila Hermon; Eylon Lahat; Gil Ben Yakov; Oranit Cohen-Ezra; Yana Davidov; Mariya Likhter; David Goitein; Susanne Roth; Achim Weber; Bernard Malissen
Journal:  Nat Med       Date:  2021-05-20       Impact factor: 53.440

Review 6.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

Review 7.  Immunopathobiology and therapeutic targets related to cytokines in liver diseases.

Authors:  Yong He; Seonghwan Hwang; Yeni Ait Ahmed; Dechun Feng; Na Li; Marcelle Ribeiro; Fouad Lafdil; Tatiana Kisseleva; Gyongyi Szabo; Bin Gao
Journal:  Cell Mol Immunol       Date:  2020-11-17       Impact factor: 11.530

Review 8.  Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.

Authors:  Yueqi Zhang; Hongbing Wang; Hua Xiao
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

Review 9.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

Review 10.  Stress kinases in the development of liver steatosis and hepatocellular carcinoma.

Authors:  Beatriz Cicuéndez; Irene Ruiz-Garrido; Alfonso Mora; Guadalupe Sabio
Journal:  Mol Metab       Date:  2021-02-13       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.